Gufic Biosciences Limited(IN:GUFICBIO)
₹432.50+8.40 (+1.98%)
IN:GUFICBIO
Gufic Biosciences Limited financials statements
₹432.50
At close:+8.40 (+1.98%)
Want to see IN:GUFICBIO full AI Analyst Report?
Gufic Biosciences Limited (GUFICBIO) Ratios
0 Followers
Gufic Biosciences Limited Ratios
IN:GUFICBIO's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:GUFICBIO's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 1.61 | 1.61 | 1.61 | 1.72 |
| Quick Ratio | 0.92 | 1.05 | 1.08 | 0.97 | 1.10 |
| Cash Ratio | 0.15 | 0.07 | 0.00 | 0.10 | 0.06 |
| Solvency Ratio | 0.14 | 0.16 | 0.18 | 0.20 | 0.45 |
| Operating Cash Flow Ratio | 0.03 | 0.26 | -0.02 | -0.09 | 0.57 |
| Short-Term Operating Cash Flow Coverage | 0.05 | 0.57 | -0.05 | -0.22 | 8.01 |
| Net Current Asset Value | ₹ 1.25B | ₹ 562.36M | ₹ 404.98M | ₹ -492.43M | ₹ 684.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.29 | 0.30 | 0.39 | 0.12 |
| Debt-to-Equity Ratio | 0.61 | 0.56 | 0.63 | 0.96 | 0.24 |
| Debt-to-Capital Ratio | 0.38 | 0.36 | 0.38 | 0.49 | 0.19 |
| Long-Term Debt-to-Capital Ratio | 0.14 | 0.18 | 0.22 | 0.35 | 0.15 |
| Financial Leverage Ratio | 2.02 | 1.95 | 2.05 | 2.48 | 1.94 |
| Debt Service Coverage Ratio | 0.42 | 0.56 | 0.66 | 0.85 | 7.01 |
| Interest Coverage Ratio | 3.29 | 4.92 | 18.84 | 30.66 | 37.02 |
| Debt to Market Cap | 0.14 | 0.09 | 0.11 | 0.17 | 0.03 |
| Interest Debt Per Share | 43.99 | 35.92 | 35.34 | 35.32 | 7.00 |
| Net Debt to EBITDA | 2.13 | 2.22 | 2.24 | 2.23 | 0.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.05% | 36.23% | 50.50% | 50.87% | 45.73% |
| EBIT Margin | 13.05% | 14.30% | 16.24% | 16.64% | 16.86% |
| EBITDA Margin | 16.31% | 16.87% | 18.35% | 19.87% | 19.06% |
| Operating Profit Margin | 12.77% | 13.86% | 35.87% | 36.51% | 16.57% |
| Pretax Profit Margin | 9.17% | 11.48% | 14.34% | 15.45% | 16.28% |
| Net Profit Margin | 6.80% | 8.50% | 10.68% | 11.54% | 12.30% |
| Continuous Operations Profit Margin | 6.80% | 8.50% | 10.68% | 11.54% | 12.30% |
| Net Income Per EBT | 74.19% | 73.98% | 74.47% | 74.69% | 75.56% |
| EBT Per EBIT | 71.82% | 82.85% | 39.97% | 42.33% | 98.25% |
| Return on Assets (ROA) | 4.78% | 5.96% | 7.88% | 9.26% | 18.38% |
| Return on Equity (ROE) | 9.66% | 11.59% | 16.17% | 22.92% | 35.61% |
| Return on Capital Employed (ROCE) | 14.61% | 14.53% | 40.16% | 44.00% | 38.54% |
| Return on Invested Capital (ROIC) | 8.06% | 8.69% | 24.27% | 26.89% | 27.79% |
| Return on Tangible Assets | 4.81% | 5.99% | 7.92% | 9.26% | 18.40% |
| Earnings Yield | 2.34% | 2.06% | 3.00% | 4.41% | 3.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.17 | 2.60 | 2.44 | 3.36 | 5.14 |
| Payables Turnover | 3.03 | 3.29 | 2.40 | 2.62 | 3.00 |
| Inventory Turnover | 1.86 | 2.41 | 1.99 | 1.86 | 3.66 |
| Fixed Asset Turnover | 1.86 | 1.57 | 1.70 | 2.10 | 5.01 |
| Asset Turnover | 0.70 | 0.70 | 0.74 | 0.80 | 1.49 |
| Working Capital Turnover Ratio | 3.62 | 3.52 | 3.99 | 4.45 | 6.74 |
| Cash Conversion Cycle | 191.09 | 180.79 | 180.56 | 165.54 | 49.08 |
| Days of Sales Outstanding | 115.24 | 140.22 | 149.29 | 108.59 | 71.00 |
| Days of Inventory Outstanding | 196.18 | 151.41 | 183.26 | 196.42 | 99.76 |
| Days of Payables Outstanding | 120.33 | 110.83 | 151.99 | 139.47 | 121.68 |
| Operating Cycle | 311.42 | 291.62 | 332.55 | 305.02 | 170.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.31 | 10.26 | -0.76 | -2.74 | 10.96 |
| Free Cash Flow Per Share | -1.80 | 2.71 | -12.19 | -22.09 | 1.94 |
| Dividend Paid and CapEx Coverage Ratio | 0.41 | 1.34 | -0.07 | -0.14 | 1.20 |
| Capital Expenditure Coverage Ratio | 0.42 | 1.36 | -0.07 | -0.14 | 1.21 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.31 | -0.02 | -0.08 | 1.65 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.13 | -0.01 | -0.04 | 0.14 |
| Free Cash Flow Yield | -0.66% | 0.80% | -4.19% | -11.85% | 0.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 42.78 | 48.63 | 33.32 | 22.67 | 25.19 |
| Price-to-Sales (P/S) Ratio | 2.91 | 4.13 | 3.56 | 2.62 | 3.10 |
| Price-to-Book (P/B) Ratio | 4.13 | 5.63 | 5.39 | 5.20 | 8.97 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -152.53 | 124.94 | -23.89 | -8.44 | 128.49 |
| Price-to-Operating Cash Flow Ratio | 208.59 | 32.99 | -384.92 | -67.97 | 22.72 |
| Price-to-Earnings Growth (PEG) Ratio | -5.32 | -2.39 | 5.27 | -1.34 | 0.22 |
| Enterprise Value Multiple | 19.97 | 26.70 | 21.63 | 15.40 | 16.61 |
| Enterprise Value | 30.76B | 36.93B | 32.02B | 21.13B | 24.67B |
| EV to EBITDA | 19.97 | 26.70 | 21.63 | 15.40 | 16.61 |
| EV to Sales | 3.26 | 4.50 | 3.97 | 3.06 | 3.17 |
| EV to Free Cash Flow | -170.77 | 136.28 | -26.65 | -9.86 | 131.30 |
| EV to Operating Cash Flow | 233.53 | 35.98 | -429.41 | -79.46 | 23.22 |
| Tangible Book Value Per Share | 65.66 | 59.46 | 53.47 | 35.81 | 27.70 |
| Shareholders’ Equity Per Share | 66.27 | 60.09 | 54.04 | 35.88 | 27.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.26 | 0.26 | 0.25 | 0.24 |
| Revenue Per Share | 94.09 | 81.96 | 81.85 | 71.24 | 80.37 |
| Net Income Per Share | 6.40 | 6.96 | 8.74 | 8.22 | 9.89 |
| Tax Burden | 0.74 | 0.74 | 0.74 | 0.75 | 0.76 |
| Interest Burden | 0.70 | 0.80 | 0.88 | 0.93 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.23 | 0.22 | 0.14 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.21 | 1.47 | -0.09 | -0.33 | 1.11 |
Currency in INR

